Cargando…

MicroRNA-22 Suppresses Breast Cancer Cell Growth and Increases Paclitaxel Sensitivity by Targeting NRAS

In recent study, microRNAs have various important functions in diverse biological processes and progression of cancer. In human breast cancer, microRNA-22 has been reported to be downregulated. However, molecular mechanism of microRNA-22 in breast cancer progression and chemosensitivity has not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Ying-kui, Wang, Yang, Wen, Yi-yang, Zhao, Pei, Bian, Zhi-jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259065/ https://www.ncbi.nlm.nih.gov/pubmed/30384806 http://dx.doi.org/10.1177/1533033818809997

Ejemplares similares

MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer
por: Liu, Xin, et al.
Publicado: (2018)

MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression
por: Tang, Xueyuan, et al.
Publicado: (2016)

MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel
por: LIU, RONGHUA, et al.
Publicado: (2014)

MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer
por: Liu, Xiaoping, et al.
Publicado: (2015)

MicroRNA-708 emerges as a potential candidate to target undruggable NRAS
por: Pang, Jia Meng, et al.
Publicado: (2023)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

Roles of microRNA‐22 in Suppressing Proliferation and Promoting Sensitivity of Osteosarcoma Cells via Metadherin‐mediated Autophagy
por: Wang, Peng, et al.
Publicado: (2019)

MicroRNA-22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells
por: Zhou, Xiang, et al.
Publicado: (2018)

Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9
por: Gong, Jian-Ping, et al.
Publicado: (2016)

Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
por: CHEN, NING, et al.
Publicado: (2014)

MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
por: Sun, Kai-Xuan, et al.
Publicado: (2015)

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
por: Zhang, J, et al.
Publicado: (2010)

Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel
por: Kopczyńska, Ewa
Publicado: (2016)

MicroRNA-206 suppresses gastric cancer cell growth and metastasis
por: Ren, Jun, et al.
Publicado: (2014)

MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart
por: Jazbutyte, Virginija, et al.
Publicado: (2012)

microRNA-181a-5p impedes the proliferation, migration, and invasion of retinoblastoma cells by targeting the NRAS proto-oncogene
por: Ouyang, Ming, et al.
Publicado: (2022)

MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells
por: Koh, Hyebin, et al.
Publicado: (2017)

microRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2
por: Yang, Yanling, et al.
Publicado: (2018)

Targeting of microRNA-22 Suppresses Tumor Spread in a Mouse Model of Triple-Negative Breast Cancer
por: Panella, Riccardo, et al.
Publicado: (2023)

Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
por: Bian, Hai-Bo, et al.
Publicado: (2011)

MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma
por: Dinh, Timothy A., et al.
Publicado: (2019)

MicroRNA-22 suppresses the growth, migration and invasion of colorectal cancer cells through a Sp1 negative feedback loop
por: Xia, Shu-Sen, et al.
Publicado: (2017)

Mechanism of microRNA‐22 in regulating neuroinflammation in Alzheimer’s disease
por: Han, Chenyang, et al.
Publicado: (2020)

BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib
por: Ranzani, Marco, et al.
Publicado: (2015)

NRAS mutant melanoma – undrugable?
por: Posch, Christian, et al.
Publicado: (2013)

MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1
por: Zou, Quanqing, et al.
Publicado: (2017)

MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1
por: Zou, Quanqing, et al.
Publicado: (2021)

MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF
por: Wang, Peisong, et al.
Publicado: (2016)

MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy
por: Zhang, Yingying, et al.
Publicado: (2018)

Suppression of pyruvate dehydrogenase kinase-2 re-sensitizes paclitaxel-resistant human lung cancer cells to paclitaxel
por: Sun, Hong, et al.
Publicado: (2017)

Selective cyclooxygenase inhibitors increase paclitaxel sensitivity in taxane-resistant ovarian cancer by suppressing P-glycoprotein expression
por: Lee, Jung-Pil, et al.
Publicado: (2013)

Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023)

Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma
por: Kumar, Raj, et al.
Publicado: (2019)

MicroRNA-217 Regulates WASF3 Expression and Suppresses Tumor Growth and Metastasis in Osteosarcoma
por: Shen, Lei, et al.
Publicado: (2014)

MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2
por: Sun, Xin-bo, et al.
Publicado: (2021)

Metabolic and energetic benefits of microRNA-22 inhibition
por: Thibonnier, Marc, et al.
Publicado: (2020)

MicroRNA-3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A
por: Shou, Taotao, et al.
Publicado: (2019)

Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness
por: Li, Qing, et al.
Publicado: (2013)

Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells
por: Wang, Chao-Jie, et al.
Publicado: (2010)

MicroRNA-22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma
por: Meng, Chen-Yang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dtd297k6pmb7rao4e90k24mou4